The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients

Table 1

Clinicopathological characteristics of 237 breast cancer patients.

Characteristics	N	%
Age
≥64	113	47.7
<64	124	52.3
Family history
Yes	116	48.9
No	121	51.1
Previous medical history
Yes	199	84.0
No	38	16.0
Age of menarche
<12	121	51.1
≥12	116	48.9
Menopause
Yes	208	87.8
No	29	12.2
Tumor size
<2 cm	61	25.7
2-5 cm	127	53.6
>5 cm	49	20.7
Pathological category
ILC	28	11.8
IDC	209	88.2
Differentiation
High	56	23.6
Medium/low	181	76.4
Clinical stages
I + II	89	37.6
III + IV	148	63.4
Lymph node metastasis
Yes	158	66.7
No	79	33.3
Distant metastasis
Yes	117	49.4
No	120	50.6
Vessel carcinoma embolus
Yes	59	21.6
No	178	78.4
Treatments
Surgery	83	35.0
Surgery + chemotherapy	82	34.6
Surgery + endocrinotherapy	72	30.4

Notes: ILC, invasive lobular carcinomas; IDC, invasive ductal carcinoma.